Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.25
Bid: 31.20
Ask: 31.45
Change: -0.20 (-0.64%)
Spread: 0.25 (0.801%)
Open: 31.00
High: 32.60
Low: 31.00
Prev. Close: 31.45
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Securitisation

19 Nov 2007 13:18

Marston's PLC19 November 2007 19 November 2007 Marston's PLC Successful Securitisation Issue Marston's PLC ("Marston's", and together with its subsidiaries the "Marston'sGroup" or "the Group") has finalised the terms of a £330m tap issue of Marston'sIssuer PLC (formerly W&DB Issuer PLC) securitisation. This is backed by thetransfer of 437 freehold and long-leasehold tenanted pubs from thenon-securitised estate to the securitised estate. The pro-forma run-rate EBITDAfor the enlarged securitisation group as at 30 June 2007 was £147.3m.Additionally, Marston's will retain £400m of its existing bank facilities.Following the tap issue only approximately £150m will be drawn against thesefacilities, providing the Group with significant financial and operationalflexibility. The terms of the tap issue are announced today and the transaction is expectedto be completed this week. The refinancing delivers significant benefits toMarston's: • highly competitive ongoing cost of funds with a weighted average margin for the tap issue of 0.80% over Libor, resulting in interest cost of the new issuance of 6.03%, including the costs of hedging.• improves the efficiency of the Group's debt funding, replacing short-term bank borrowing with long term securitised financing.• enhanced operational and financial flexibility within the revised debt structure.• all of the Group's debt is now at effective fixed rates of interest, with no refinancing risk or exposure to volatile credit markets. Marston's tap issue is the only pub securitisation, and one of the very fewsecuritisations in Europe, to have been launched successfully and priced inrecent months. Paul Inglett, Group Finance Director, said "Despite adverse market conditions,the terms of the refinancing demonstrate the strength of Marston's creditprofile and the high quality of its pub estate". The securitisation tap issue has been pre-placed. The pricing of the tap issueis in line with previous pub securitisations and is very competitive given thecurrent difficult conditions in the securitisation markets. The securitisationtap issue priced at the following levels: Tranche Rating (S&P/F) Type Maturity Amount Coupon A4 A/A FRN 2031 £250m Libor + 65 bps1AB1 BBB+/BBB+ FRN 2035 £80m Libor + 125 bps1Total £330m Libor + 80 bps2 Note 1: The FRNs are fully hedged and will be issued at a discount to par priceof 99.95%Note 2: This is the weighted average margin to a step-up in coupon at year 5 As a result of the interest rate swaps put in place in October and the £330m tapof the securitisation, all of the Group's borrowings are now effectively atfixed rates of interest with a blended average cost of debt of approximately6.1%. Marston's will be holding a bondholder presentation on Monday 3rd December at9.30am at the offices of Hudson Sandler, 29 Cloth Fair, London, EC1A 7NN. Pleasecontact Vanessa Laybourn at Hudson Sandler on 020 7796 4133 for details. The Royal Bank of Scotland plc acted as the Arranger, Joint Bookrunner and JointLead Manager in the transaction. HSBC Bank plc is a Joint Bookrunner and JointLead Manager and Barclays Capital is a Joint Lead Manager on the transaction. NMRothschild & Sons Limited advised Marston's on its refinancing strategy. Contact details Marston's PLC Ralph Findlay, Chief Executive 01902 329 516Paul Inglett, Group Finance Director 01902 329 516 The Royal Bank of Scotland plc (Arranger and Joint Bookrunner) Colin Lally, Director 020 7085 6668Paul Crawford, Director 020 7085 5165 NM Rothschild & Sons Limited (Financial Adviser to Marston's) Tom Smyth, Managing Director 020 7280 5719Swagata Ganguly, Assistant Director 020 7280 5676 Hudson Sandler (PR Adviser to Marston's) Andrew Hayes 020 7796 4133Nick Lyon 020 7796 4133 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jun 20244:07 pmRNSHolding(s) in Company
14th May 20247:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 30 MARCH 2024
13th May 20243:42 pmRNSHolding(s) in Company
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
28th Jun 20234:54 pmRNSDirector/PDMR Shareholding
27th Jun 20234:11 pmRNSDirector/PDMR Shareholding
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.